SEC FORM 3

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sugrue Stephen

(Last)

(First)

(Middle)

C/O DOCGO INC.

35 WEST 35TH STREET, FLOOR 6

(Street)

NEW YORK

10001

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/11/2022

3. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Compliance Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option to Buy	01/05/2022	01/07/2031	Common stock	16,129⁽¹⁾	3.25	D
Option to Buy	12/07/2022	12/07/2031	Common stock	250⁽²⁾	8.8	D
Option to Buy	01/05/2023	01/07/2031	Common stock	16,129⁽¹⁾	3.25	D
Option to Buy	12/07/2023	12/07/2031	Common stock	250⁽²⁾	8.8	D
Option to Buy	01/05/2024	01/07/2031	Common stock	16,129⁽¹⁾	3.25	D
Option to Buy	12/07/2024	12/07/2031	Common stock	250⁽²⁾	8.8	D
Option to Buy	01/05/2025	01/07/2031	Common stock	16,129⁽¹⁾	3.25	D
Option to Buy	12/07/2025	12/07/2031	Common stock	250⁽²⁾	8.8	D

Explanation of Responses:

1. Mr. Sugrue was granted 64,515 (as converted) options on January 7, 2021, vesting 25% annually over a four-year period.

2. Mr. Sugrue was granted 1,000 options on December 7, 2021, vesting 25% annually over a four-year period.

Remarks:

Exhibit. 24.1 Power of Attorney

	/s/ Ely Tendler, Attorney-in-fact for Stephen Sugrue	03/21/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 3 filed by new insider Sugrue Stephen